日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Neosartorya fumigata Probable exopolygalacturonase C (pgxC) CSB-YP537758NGT
CSB-EP537758NGT
CSB-BP537758NGT
CSB-MP537758NGT
CSB-EP537758NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Lipoyl synthase, mitochondrial (AFUB_042490) CSB-YP537759NGT
CSB-EP537759NGT
CSB-BP537759NGT
CSB-MP537759NGT
CSB-EP537759NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Elastase inhibitor AFLEI (AFUB_034300) CSB-YP537760NGT
CSB-EP537760NGT
CSB-BP537760NGT
CSB-MP537760NGT
CSB-EP537760NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Metacaspase-1B (casB), partial CSB-YP537761NGT
CSB-EP537761NGT
CSB-BP537761NGT
CSB-MP537761NGT
CSB-EP537761NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata MYND-type zinc finger protein samB (samB), partial CSB-YP537762NGT
CSB-EP537762NGT
CSB-BP537762NGT
CSB-MP537762NGT
CSB-EP537762NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Aspartic protease pep1 (pep1) CSB-YP537763NGT
CSB-EP537763NGT
CSB-BP537763NGT
CSB-MP537763NGT
CSB-EP537763NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Solute carrier family 25 member 38 homolog (AFUB_069300), partial CSB-YP537764NGT1
CSB-EP537764NGT1
CSB-BP537764NGT1
CSB-MP537764NGT1
CSB-EP537764NGT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable cutinase 2 (AFUB_071270) CSB-YP537765NGT
CSB-EP537765NGT
CSB-BP537765NGT
CSB-MP537765NGT
CSB-EP537765NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Protein get1 (get1), partial CSB-YP537766NGT1
CSB-EP537766NGT1
CSB-BP537766NGT1
CSB-MP537766NGT1
CSB-EP537766NGT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Elongation factor G, mitochondrial (mef1), partial CSB-YP537767NGT
CSB-EP537767NGT
CSB-BP537767NGT
CSB-MP537767NGT
CSB-EP537767NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Kynureninase 2 (bna5-2) CSB-YP537768NGT
CSB-EP537768NGT
CSB-BP537768NGT
CSB-MP537768NGT
CSB-EP537768NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Alkaline protease 1 (alp1) CSB-YP537769NGT
CSB-EP537769NGT
CSB-BP537769NGT
CSB-MP537769NGT
CSB-EP537769NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable beta-mannosidase A (mndA), partial CSB-YP537770NGT
CSB-EP537770NGT
CSB-BP537770NGT
CSB-MP537770NGT
CSB-EP537770NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable beta-glucosidase J (bglJ), partial CSB-YP537771NGT
CSB-EP537771NGT
CSB-BP537771NGT
CSB-MP537771NGT
CSB-EP537771NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable mannan endo-1,4-beta-mannosidase F (manF) CSB-YP537772NGT
CSB-EP537772NGT
CSB-BP537772NGT
CSB-MP537772NGT
CSB-EP537772NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata 3-hydroxyanthranilate 3,4-dioxygenase 1 (bna1-1) CSB-YP537773NGT
CSB-EP537773NGT
CSB-BP537773NGT
CSB-MP537773NGT
CSB-EP537773NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Probable exopolygalacturonase B (pgxB) CSB-YP537774NGT
CSB-EP537774NGT
CSB-BP537774NGT
CSB-MP537774NGT
CSB-EP537774NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Actin cytoskeleton-regulatory complex protein pan1 (pan1), partial CSB-YP537775NGT
CSB-EP537775NGT
CSB-BP537775NGT
CSB-MP537775NGT
CSB-EP537775NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Leucine aminopeptidase 1 (lap1) CSB-YP537776NGT
CSB-EP537776NGT
CSB-BP537776NGT
CSB-MP537776NGT
CSB-EP537776NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fumigata Neutral protease 2 homolog AFUB_100460 (AFUB_100460) CSB-YP537777NGT
CSB-EP537777NGT
CSB-BP537777NGT
CSB-MP537777NGT
CSB-EP537777NGT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×